Clinical Trials Directory

Trials / Completed

CompletedNCT03884920

Glucose Tolerance and Prevention of Diabetes Mellitus Type 2 by Polyherbal Formulation

Impaired Glucose Tolerance and Prevention of Diabetes Mellitus Type 2 by Polyherbal Formulation of Eastern Medicine

Status
Completed
Phase
Study type
Observational
Enrollment
57 (actual)
Sponsor
Islamia University of Bahawalpur · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Accepted

Summary

Primary protocol to this study is to develop a natural remedy to prevent diabetes mellitus in pre-diabetic state and elaborate the effectiveness of polyherbal formulation for carrying out Phase-II, III and IV. It also aimed at to see the level of difference of glucose tolerance and impaired fasting glucose and impaired glucose tolerance between pre-diabetic and diabetic to evaluate the potential benefit for treatment of insulin resistance and sensitivity. To see the for prevention of Diabetes Mellitus (DM) and stopping / delaying the onset of DM.

Detailed description

This study is a clinical trial study to evaluate the potential of prevention in pre-diabetics and to prevent onset of diabetes mellitus. For this purpose, volunteers will be enrolled in the study by observing the Helsinki Declaration for clinical trials. volunteers will be screened for the impaired glucose tolerance or impaired fasting glucose or at risk to develop diabetes mellitus type 2. On screening, pre-diabetics and early onset diabetics with no previous history of treatment etc will be grouped into A and B. Biochemical evaluations will be carried out at base line and followed by three weeks intervention and evaluation of biomarkers and at sixth week for further evaluation. Collected data will be evaluated for primary out comes and secondary out come. statistical analysis will be done. One year followup of participants was conducted.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPolyherbal formulationTest candidate will be administered per oral before / with meal in two divided doses

Timeline

Start date
2019-03-20
Primary completion
2019-05-05
Completion
2021-12-30
First posted
2019-03-21
Last updated
2022-02-22

Locations

2 sites across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT03884920. Inclusion in this directory is not an endorsement.